[go: up one dir, main page]

WO2000008145A3 - Nouveaux genes de regulation de l'hematopoiese - Google Patents

Nouveaux genes de regulation de l'hematopoiese Download PDF

Info

Publication number
WO2000008145A3
WO2000008145A3 PCT/EP1999/005566 EP9905566W WO0008145A3 WO 2000008145 A3 WO2000008145 A3 WO 2000008145A3 EP 9905566 W EP9905566 W EP 9905566W WO 0008145 A3 WO0008145 A3 WO 0008145A3
Authority
WO
WIPO (PCT)
Prior art keywords
scm
hematopoiesis
control
novel genes
genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP1999/005566
Other languages
English (en)
Other versions
WO2000008145A2 (fr
Inventor
Michael Paul Cooke
Claire Louise Holness
Oksana Ivanivna Sirenko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Pharma GmbH Austria
Novartis AG
Original Assignee
Novartis Erfindungen Verwaltungs GmbH
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Erfindungen Verwaltungs GmbH, Novartis AG filed Critical Novartis Erfindungen Verwaltungs GmbH
Priority to EP99944319A priority Critical patent/EP1100914A2/fr
Priority to JP2000563772A priority patent/JP2002524040A/ja
Priority to AU57300/99A priority patent/AU5730099A/en
Priority to CA002337904A priority patent/CA2337904A1/fr
Publication of WO2000008145A2 publication Critical patent/WO2000008145A2/fr
Publication of WO2000008145A3 publication Critical patent/WO2000008145A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne trois nouveaux gènes HSC appelés SCM 3, SCM 26 et SCM 113, leurs zones de codage, les produits géniques, des applications des ces gènes, des produits de synthèse d'ADN, des vecteurs et des cellules modifiées comprenant chacune le gène en question ou un fragment de celui-ci. Par ailleurs, cette invention concerne des procédés d'utilisation des séquences polynucléotidiques et polypeptidiques des SCM 3, SCM 26, et SCM 113.
PCT/EP1999/005566 1998-08-03 1999-08-02 Nouveaux genes de regulation de l'hematopoiese Ceased WO2000008145A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP99944319A EP1100914A2 (fr) 1998-08-03 1999-08-02 Nouveaux genes de regulation de l'hematopoiese
JP2000563772A JP2002524040A (ja) 1998-08-03 1999-08-02 造血の制御における新規遺伝子
AU57300/99A AU5730099A (en) 1998-08-03 1999-08-02 Novel genes in control of hematopoiesis
CA002337904A CA2337904A1 (fr) 1998-08-03 1999-08-02 Nouveaux genes de regulation de l'hematopoiese

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12831098A 1998-08-03 1998-08-03
US09/128,310 1998-08-03

Publications (2)

Publication Number Publication Date
WO2000008145A2 WO2000008145A2 (fr) 2000-02-17
WO2000008145A3 true WO2000008145A3 (fr) 2000-06-29

Family

ID=22434708

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1999/005566 Ceased WO2000008145A2 (fr) 1998-08-03 1999-08-02 Nouveaux genes de regulation de l'hematopoiese

Country Status (5)

Country Link
EP (1) EP1100914A2 (fr)
JP (1) JP2002524040A (fr)
AU (1) AU5730099A (fr)
CA (1) CA2337904A1 (fr)
WO (1) WO2000008145A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030060407A1 (en) 1997-06-16 2003-03-27 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7264801B2 (en) 1998-08-11 2007-09-04 Genentech, Inc. EG-VEGF nucleic acids and polypeptides and method of use
US20020172678A1 (en) 2000-06-23 2002-11-21 Napoleone Ferrara EG-VEGF nucleic acids and polypeptides and methods of use
US20030003507A1 (en) 1999-06-02 2003-01-02 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
CA2383254A1 (fr) * 1999-06-02 2000-12-07 Genentech, Inc. Polypeptides transmembranaires secretes et acides nucleiques codants pour ceux-ci

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998012306A1 (fr) * 1996-09-23 1998-03-26 Ontogeny, Inc. Cellules souches hematopoietiques et procedes relatifs a leur production
WO1998039448A2 (fr) * 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 186 nouvelles proteines secretees
WO1998042741A2 (fr) * 1997-03-25 1998-10-01 Genetics Institute, Inc. Proteines secretees et polynucleotides les codant
WO1998045436A2 (fr) * 1997-04-10 1998-10-15 Genetics Institute, Inc. Marqueurs secretes de sequence exprimee (sest)

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998012306A1 (fr) * 1996-09-23 1998-03-26 Ontogeny, Inc. Cellules souches hematopoietiques et procedes relatifs a leur production
WO1998039448A2 (fr) * 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 186 nouvelles proteines secretees
WO1998042741A2 (fr) * 1997-03-25 1998-10-01 Genetics Institute, Inc. Proteines secretees et polynucleotides les codant
WO1998045436A2 (fr) * 1997-04-10 1998-10-15 Genetics Institute, Inc. Marqueurs secretes de sequence exprimee (sest)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE EMEST29 E.M.B.L. Databases; 15 December 1996 (1996-12-15), HILLIER L ET AL: "Homo sapiens cDNA clone 491654 5'", XP002130036 *

Also Published As

Publication number Publication date
CA2337904A1 (fr) 2000-02-17
WO2000008145A2 (fr) 2000-02-17
AU5730099A (en) 2000-02-28
EP1100914A2 (fr) 2001-05-23
JP2002524040A (ja) 2002-08-06

Similar Documents

Publication Publication Date Title
EP0804609A4 (fr) NOUVEAUX GENES DE REPONSE p53
WO1995004146A3 (fr) Genes et proteines de toxine cryet4 et cryet5 du bacillus thuringiensis, a pouvoir toxique contre les lepidopteres
IL122403A0 (en) Recombinant dna vector comprising aav nucleic acid sequences
WO2000006738A3 (fr) Acides nucleiques et proteines de streptococcus pneumoniae
CA2120514A1 (fr) Sequence synthetique d'adn a activite insecticide amelioree dans le mais
WO2004101759A3 (fr) Nouvelle enzyme lipolytique lip2
WO1998056927A3 (fr) Acides nucleiques codant des polypeptides a fonction protease
WO1997012972A3 (fr) Genes regules et leurs utilisations
WO1998021343A8 (fr) Genes codant des proteines de telomerase
AU6277799A (en) Il-17 homolog nucleic acids, polypeptides, vectors, host cells, methods and usesthereof
EP0828003A3 (fr) Sérine protéase humaine
WO2003060143A3 (fr) Systeme d'expression de proteine efficace
WO1999057282A3 (fr) Toxines pesticides et sequences nucleotidiques codant pour ces toxines
CA2281206A1 (fr) Genes de geranyl diphosphate synthase
WO2000043490A3 (fr) Gene de la rhamnosyl-tansferase et utilisations associees
WO2000008145A3 (fr) Nouveaux genes de regulation de l'hematopoiese
WO2004035799A3 (fr) Vecteurs viraux et leur utilisation en thérapie génique
CA2245584A1 (fr) Expression par recombinaison de proteines de couche superficielle
GB9421093D0 (en) Hippocampus-associated proteins, DNA sequences coding therefore and uses thereof
WO1998044134A3 (fr) Plasmides bacteriens
AU2904495A (en) Borrelia burgdorferi exported plasmid protein a, nucleic acids encoding thereof, and uses thereof
AU1440695A (en) P53-based polypeptide fragments, nucleic acid molecules encoding same, and uses thereof
AU1137699A (en) Novel reovirus-derived proteins, nucleic acids encoding same, and uses therefor
AU5627090A (en) A novel alpha-amylase-pullulanase enzyme, a dna sequence coding the same, a recombinant dna molecule and a recombinant clone expressing the enzyme
AU8772598A (en) Dna encoding the human synapsin iii gene and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 1999944319

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2337904

Country of ref document: CA

Ref country code: CA

Ref document number: 2337904

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 09775742

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1999944319

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1999944319

Country of ref document: EP